Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health Care Savings From Lutein, Zeaxanthin Becoming Clear – Study

This article was originally published in The Tan Sheet

Executive Summary

Daily intake of 6 to 10 mg of lutein with zeaxanthin by people at risk for age-related macular degeneration could generate $3.6 billion in net health care savings over a five-year period, according to an economic analysis
Advertisement

Related Content

Study to examine vitamin D, omega-3 supplements
Study to examine vitamin D, omega-3 supplements
Study to examine vitamin D, omega-3 supplements
Supplement Industry Strongly Contributes To Economic Health – Report
Supplement Industry Strongly Contributes To Economic Health – Report
Supplement Industry Strongly Contributes To Economic Health – Report
Carotenoids, Anitoxidants Improve Treatment For AMD – Study
Lutein, Omega-3 Uptake Would Save Healthcare System Billions, DSEA Claims
Lutein, Omega-3 Uptake Would Save Healthcare System Billions, DSEA Claims

Topics

Advertisement
UsernamePublicRestriction

Register

PS102145

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel